MedPath

Asymptomatic Narrow Angles - Laser Iridotomy Study; Multicentric RCT

Not Applicable
Conditions
Asymptomatic Narrow Angles
Primary Angle Closure Suspects
Registration Number
NCT00347178
Lead Sponsor
Singapore National Eye Centre
Brief Summary

This is a multicentric, randomised, controlled study comparing Laser Iridotomy (LI) to no treatment in subjects with asymptomatic narrow angles (ANA).One eye of each subject with ANA will be randomised to undergo LI and the other eye will be left alone and will serve as an internal control. Subjects are proposed to be followed up once a year for 5 years.

Detailed Description

Objective: This study will compare LI versus no treatment in subjects with asymptomatic narrow angles, the anatomical trait that predisposes to primary angle closure glaucoma (PACG), in order to assess the effectiveness of prophylactic treatment in the prevention of blindness due to PACG.

Eligibility: 1. Bilateral Narrow angles; 2. Age 50 years and above; 3. Informed consent obtained prior to or at baseline visit.

Trial Design: Subjects with asymptomatic ANA undergoes randomisation after comprehensive ocular exam followed by randomisation to LI in one eye and no treatment in the other eye. Follow up is done for 5 years with yearly examination.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
544
Inclusion Criteria
  1. Bilateral Narrow angles
  2. Age 50 years and above
  3. Informed consent obtained prior to or at baseline visit
Exclusion Criteria
  1. Presence of PAS
  2. IOP > 21 mm Hg
  3. Glaucomatous optic neuropathy and/or CDR > 0.7
  4. Secondary angle closure such as uveitis, neovascularisation etc.
  5. Prior intraocular surgery or penetrating eye injury
  6. Corneal disorders such as corneal endothelial dystrophy except mild corneal guttae
  7. Evidence of prior acute angle closure event
  8. High risk of acute angle closure.
  9. Significant cataract and visual acuity less than 20/40
  10. Constant use of contact lens for refractive correction
  11. Chronic use of topical or systemic steroids
  12. Established retinopathies on ocular treatments (e.g. Diabetic)
  13. Any other disease which is likely to cause field loss in next 3 years
  14. Severe health problems decreasing life expectancy to less than one year.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Peripheral anterior synechiae formation
IOP elevation >21 mm Hg
Development of acute angle closure event
Secondary Outcome Measures
NameTimeMethod
Changes in the grading of Modified Schaffer Grading
Development of glaucomatous optic neuropathy
Development of corresponding visual field loss by automated perimetry
Change in HRT optic disc parameters
Change in UBM angle parameters
Formation of disc pallor

Trial Locations

Locations (1)

Singapore Eye Research Institute

🇸🇬

Singapore, Singapore

Singapore Eye Research Institute
🇸🇬Singapore, Singapore
Tin Aung, FRCSEd, PhD
Principal Investigator
Steve KL Seah, FRCS (Ed)
Sub Investigator
Paul TK Chew, FRCS (Ed)
Sub Investigator
Hon T Wong, FRCS (Ed)
Sub Investigator
Aliza - Jap, FRCOph (Lon)
Sub Investigator
Kah G AuEong, FRCS (Ed)
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath